Gorman Kevin Charles's Form 4 filing
Neurocrine Biosciences Inc (NBIX) · filed Feb 14, 2025
- Accession no.
- 0000914475-25-000073
- Filed
- Feb 14, 2025
- Trade date
- Feb 13, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $681.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gorman Kevin CharlesCIK 0001201096 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2025 | Common Stock | MOption exerciseAcquired | +5,376 | $0.00 | $0 | 524,450 | Direct | |
| Feb 13, 2025 | Common Stock | SSaleDisposed | −2,832 | $116.69 | −$330,466.08 | 521,618 | Direct | |
| Feb 13, 2025 | Common Stock | MOption exerciseAcquired | +5,603 | $0.00 | $0 | 527,221 | Direct | |
| Feb 13, 2025 | Common Stock | SSaleDisposed | −3,012 | $116.68 | −$351,440.16 | 524,209 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2025 | Common Stock | MOption exerciseDisposed | −5,376 | $0.00 | $0 | 10,754 | Direct | |
| Feb 13, 2025 | Common Stock | MOption exerciseDisposed | −5,603 | $0.00 | $0 | 16,812 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.